©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: Controlled Substances Act
Historic Vote: U.S. House Overturns Cannabis Prohibition
WASHINGTON, D.C. – The Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H.R. 3884, made history today as members of the House of Representatives voted...
MORE Act Headed to House Floor Vote by Friday
WASHINGTON, D.C. – The Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act, H.R. 3884, is headed to a vote on the floor of the U.S....
Congress Set to Vote on MORE Act This Week
WASHINGTON, D.C. – The U.S. House of Representatives will hold a floor vote on the Marijuana Opportunity Reinvestment and Expungement (MORE) Act this week,...
Hemp Industry Members File Suit Over DEA Regulatory Overreach
WASHINGTON, D.C. – The Hemp Industry Association (HIA) and RE Botanicals, Inc. on Monday filed a complaint in federal court against the Drug Enforcement...
Plaintiffs in U.S. Supreme Court Cannabis Appeal Backed by Amicus Briefs
NEW YORK – A three-year-old case that initially was filed in lower courts and recently filed in the U.S. Supreme Court has received tremendous...
IRS Publishes Tax Information for the Cannabis Industry
WASHINGTON, D.C. – The Internal Revenue Service (IRS) has posted an online resource page for the legal cannabis industry. The action comes after the...
House Set to Vote on Federal Marijuana Decriminalization
WASHINGTON D.C. – The U.S. House this September will vote on the Marijuana Opportunity Reinvestment and Expungement Act of 2019, or MORE Act, which...
DEA Interim Final Rule Sparks Concern Over Hemp, CBD Product Manufacturing
WASHINGTON, D.C. – The U.S. Drug Enforcement Administration (DEA) issued an interim final rule (IFR) regarding provisions implemented by the 2018 Farm Act and,...
Cannabis and Coronavirus: Industry Donations and Fundraising Efforts Continue
Ed. Note: This story is part of a continuing series about the cannabis industry’s humanitarian efforts during the coronavirus, COVID-19 pandemic.
It has been about...
Key DEA Change Could Make Cannabis-Based Medicine More Accessible
Washington D.C. – The Drug Enforcement Administration (DEA) is making policy changes that could make it easier for patients to access Epidiolex.
Epidiolex, produced by...